To gain insight into the link between earlier events in AD pathogenesis and the JNK pathway, we next evaluated 3.5 months as a time point representative of an early symptomatic phase with the beginning of a mild cognitive decline. The gene discussed is MAPK8; the disease is Alzheimer disease.